Amgen Inc. Stock Advances 4.3%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Amgen Inc. advanced 4.3% to $410.24 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,764.64 and the Dow Jones Industrial Average falling 0.4% to 51,863.69.

This was the stock's fifth consecutive day of gains.

Amgen Inc. closed 8.2% short of its 52-week high of $447.03, which the company achieved on August 25th.

The stock outperformed some of its peers, as Johnson & Johnson fell 0.1% to $269.19, Pfizer Inc. rose 0.7% to $27.93, and AbbVie Inc. rose 0.28% to $265.21.

Trading volume totaled 3.5 million, compared to the 50-day average of 2.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 22, 2026 16:35 ET (20:35 GMT)